Analysen von Richard Vosser
| 28.04.21 | Merck overweight | JP Morgan Chase & Co. | |
| 27.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 26.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 23.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 21.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 19.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 14.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 13.04.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 09.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.04.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 07.04.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.04.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 07.04.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 24.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 23.03.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 23.03.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.03.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.03.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 19.03.21 | Nike overweight | JP Morgan Chase & Co. | |
| 17.03.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 16.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 15.03.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 12.03.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 10.03.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 05.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 04.03.21 | Merck overweight | JP Morgan Chase & Co. | |
| 03.03.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 25.02.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 15.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 12.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 10.02.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 09.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 05.02.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.02.21 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.02.21 | Merck overweight | JP Morgan Chase & Co. | |
| 02.02.21 | Bayer Neutral | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius Stedim Biotech overweight | JP Morgan Chase & Co. | |
| 29.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 28.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
| 27.01.21 | Sartorius vz. overweight | JP Morgan Chase & Co. | |
| 27.01.21 | Sanofi overweight | JP Morgan Chase & Co. | |
| 26.01.21 | Novo Nordisk overweight | JP Morgan Chase & Co. | |